Search
01/05/2022
Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach
Esmel-Vilomara, R, Dolader, P, Izquierdo-Blasco, J, Balcells, J, Sorli, M, Escudero, F, Vera, E, Gran, F. Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach. EUROPEAN JOURNAL OF PEDIATRICS. 2022; 181(5)DOI:10.1007/s00431-022-04406-x. PMID:35138467. IF:3.600(Q1/2D).
01/05/2022
Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases
Bullich G., Matalonga L., Pujadas M., Papakonstantinou A., Piscia D., Tonda R., Artuch R., Gallano P., Garrabou G., González J.R., Grinberg D., Guitart M., Laurie S., Lázaro C., Luengo C., Martí R., Milà M., Ovelleiro D., Parra G., Pujol A., Tizzano E., Macaya A., Palau F., Ribes A., Pérez-Jurado L.A., Beltran S., Schlüter A., Rodriguez-Palmero A., Cáceres A., Nascimento A., García-Cazorla À., Cueto-González A., Marcé-Grau A., Nel.lo A.R., Martínez-Monseny A., Sànchez A., García B., Pérez-Dueñas B., Gel B., Fusté B., Hernández-Ferrer C., Casasnovas C., Ortez C., Arjona C., Hernando-Davalillo C., de Benito D.N., Amador D.P., Gómez-Andrés D., Yubero D., Pelegrí-Sisó D., Verdura E., García-Arumí E., Castellanos E., Gabau E., Tobías E., López-Grondona F., Cardellach F., Garcia-Garcia F.J., Munell F., Tort F., Aznar G., Olivé-Cirera G., Tell G., Muñoz-Pujol G., Paramonov I., Blanco I., Madrigal I., Valenzuela I., Gut I., Cusco I., Trotta J.-R., Cruz J., Díaz-Manera J., Milisenda J.C., Ma Grau J., Garcia-Villoria J., Armstrong J., Cantó J., Sala-Coromina J., Rodríguez-Revenga L., Alias L., Gort L., González-Quereda L., Costa M., Fernández-Callejo M., López-Sánchez M., Álvarez-Mora M.I., Gut M., Serrano M., Raspall-Chaure M., Toro M.D., Bayés M., Díez N.B., Spataro N., Capdevila N., Ugarteburu O., Muñoz-Cabello P., Duque P.R., Rabionet R., Rojas-García R., Calvo R., Urreizti R., Bernal S., Boronat S., Balcells S., Vendrell T.. Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases. JOURNAL OF MOLECULAR DIAGNOSTICS. 2022; 24(5)DOI:10.1016/j.jmoldx.2022.02.003. PMID:35569879. IF:4.100(Q2/3D).
01/05/2022
Digital PET vs Analog PET: Clinical Implications?
López-Mora D.A., Carrió I., Flotats A.. Digital PET vs Analog PET: Clinical Implications?. SEMINARS IN NUCLEAR MEDICINE. 2022; 52(3)DOI:10.1053/j.semnuclmed.2021.10.004. PMID:34836617. IF:4.900(Q1/2D).
01/05/2022
The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?
Lopez-Delgado, JC, Grau-Carmona, T, Trujillano-Cabello, J, Garcia-Fuentes, C, Mor-Marco, E, Bordeje-Laguna, ML, Portugal-Rodriguez, E, Lorencio-Cardenas, C, Vera-Artazcoz, P, Macaya-Redin, L, Martinez-Carmona, JF, Mateu-Campos, L, Gero-Escapa, M, Gastaldo-Simeon, R, Vila-Garcia, B, Flordelis-Lasierra, JL, Montejo-Gonzalez, JC, Servia-Goixart, L. The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?. Nutrients. 2022; 14(9)DOI:10.3390/nu14091904. PMID:35565870. IF:5.900(Q1/2D).
01/05/2022
Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
Moreno-Martinez, E, de la Serna-Torroba, J, Escudero-Vilaplana, V, Hernandez-Rivas, JA, Sanchez-Cuervos, M, Sanchez-Hernandez, R. Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain. Farmacia Hospitalaria. 2022; 46(3)DOI:10.7399/fh.11829. PMID:36183205. IF:(Q/D).
01/05/2022
Autochthonous and imported tegumentary leishmaniasis in Catalonia (Spain): Aetiological evolution in the last four decades and usefulness of different typing approaches based on biochemical, molecular and proteomic markers
Fernandez-Arevalo, A, Ballart, C, Munoz-Basagoiti, J, Basarte, L, Lobato, G, Arnau, A, Abras, A, Tebar, S, Llovet, T, Lami, P, Pratlong, F, Alsina, M, Roe, E, Puig, L, Munoz, C, Gallego, M. Autochthonous and imported tegumentary leishmaniasis in Catalonia (Spain): Aetiological evolution in the last four decades and usefulness of different typing approaches based on biochemical, molecular and proteomic markers. Transboundary and Emerging Diseases. 2022; 69(3)DOI:10.1111/tbed.14107. PMID:33864706. IF:4.300(Q1/1D).